This Project combines preclinical work in animals and human post mortem studies to focus on the interaction of the stress system and the noradrenergic (NE) system in the modulation of emotional behavioral and mood disorders. While the NE system has long been implicated in stress responsiveness and in the etiology of depression, we lack some information on the anatomical interface between stress-related and NE- related genes. Thus, describing the interface is one of our first goals. In addition, we plan to study the role of the NE system in mediating individual differences in emotional responsiveness, by relying on a model of spontaneous differences in emotional reactivity in which rats have distinctive patterns of behavior in anxiety-like conditions. Thus, some animals termed high responders (HR) show a great deal of exploration, while others, termed low responders (LR) appear quite timed. These animals with differing emotional predisposition have differing patterns of expression of stress-related genes. We will investigate whether they also exhibit in the expression of NE-related genes in brain circuits implicated in emotional control. We will use chronic, non-habituating stress as a challenge to place demand on the emotional circuitry and study the neurobiological consequences in the NE and stress systems of the HR and LR animals. We will study the possible reversal of these effects by particular classes of anti-depressants (SSRI vs. Noradrenergic drugs_. We will then move to human post- mortem studies to characterize the neuronal phenotype (pattern of expression of relevant genes) of severely depressed individuals versus individually matched controls. While our starting place in this project is the noradrenergic system, we will related our observations to the patterns of expression of stress- and serotonin genes. This work will directly compare the contributions of two critical monoaminergic systems that have been implicated in mood disorders and will link the animal findings to studies in the human brain.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Program Projects (P01)
Project #
2P01MH042251-16
Application #
6589935
Study Section
Special Emphasis Panel (ZMH1)
Project Start
2002-04-16
Project End
2006-11-30
Budget Start
Budget End
Support Year
16
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Crane, Natania A; Jenkins, Lisanne M; Bhaumik, Runa et al. (2017) Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI. Brain 140:472-486
Hillhouse, Todd M; Porter, Joseph H (2015) A brief history of the development of antidepressant drugs: from monoamines to glutamate. Exp Clin Psychopharmacol 23:1-21
Meyers, K K; Crane, N A; O'Day, R et al. (2015) Smoking history, and not depression, is related to deficits in detection of happy and sad faces. Addict Behav 41:210-7
Lohoff, F W; Hodge, R; Narasimhan, S et al. (2014) Functional genetic variants in the vesicular monoamine transporter 1 modulate emotion processing. Mol Psychiatry 19:129-39
Tomita, Hiroaki; Ziegler, Mary E; Kim, Helen B et al. (2013) G protein-linked signaling pathways in bipolar and major depressive disorders. Front Genet 4:297
Votruba, Kristen L; Langenecker, Scott A (2013) Factor structure, construct validity, and age- and education-based normative data for the Parametric Go/No-Go Test. J Clin Exp Neuropsychol 35:132-46
Turner, Cortney A; Watson, Stanley J; Akil, Huda (2012) The fibroblast growth factor family: neuromodulation of affective behavior. Neuron 76:160-74
Vederman, Aaron C; Weisenbach, Sara L; Rapport, Lisa J et al. (2012) Modality-specific alterations in the perception of emotional stimuli in Bipolar Disorder compared to Healthy Controls and Major Depressive Disorder. Cortex 48:1027-34
Turner, Cortney A; Clinton, Sarah M; Thompson, Robert C et al. (2011) Fibroblast growth factor-2 (FGF2) augmentation early in life alters hippocampal development and rescues the anxiety phenotype in vulnerable animals. Proc Natl Acad Sci U S A 108:8021-5
Mickey, Brian J; Zhou, Zhifeng; Heitzeg, Mary M et al. (2011) Emotion processing, major depression, and functional genetic variation of neuropeptide Y. Arch Gen Psychiatry 68:158-66

Showing the most recent 10 out of 75 publications